Survival analysis of the prospectively randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy with weekly nab-paclitaxel with solvent-based paclitaxel followed by anthracycline/cyclophosphamide for patients with early breast cancer – GBG 69 - Schneeweiss, A; Jackisch, C; Schmatloch, S
SABCS 2017; Abstr. GS3-05